Cochlear Boosts Nyxoah Stake to 16.7%

TL;DR

Cochlear just upped its Nyxoah stake to 16.7% - big move!

AI Summary

Cochlear Investments Pty Ltd, an affiliate of Cochlear Limited, has amended its Schedule 13D filing regarding Nyxoah SA. The filing, dated October 10, 2024, indicates a change in beneficial ownership. Cochlear Investments Pty Ltd now holds 10,000,000 ordinary shares of Nyxoah SA, representing approximately 16.7% of the outstanding shares.

Why It Matters

This increased stake by a significant medical device company like Cochlear could signal strategic interest or a potential future acquisition of Nyxoah, impacting its stock and competitive landscape.

Risk Assessment

Risk Level: medium — The filing indicates a change in beneficial ownership, which could lead to market speculation and price volatility for Nyxoah SA.

Key Numbers

• 10,000,000 — Shares Held (Cochlear Investments Pty Ltd's stake in Nyxoah SA)
• 16.7% — Ownership Percentage (Cochlear Investments Pty Ltd's beneficial ownership of Nyxoah SA)

Key Players & Entities

• Cochlear Investments Pty Ltd (company) — Filing entity
• Cochlear Limited (company) — Parent company of filing entity
• Nyxoah SA (company) — Subject company
• Rob McGrory (person) — Group General Counsel & Company Secretary of Cochlear Limited
• 10,000,000 (dollar_amount) — Number of ordinary shares held

FAQ

Filing Documents

• tm2425979d1_sc13da.htm (SC 13D/A) — 36KB
• 0001104659-24-107702.txt ( ) — 38KB

of the Schedule 13D is hereby amended and supplemented by the

Item 5 of the Schedule 13D is hereby amended and supplemented by the following information: (a) – (b) As of the date hereof, Cochlear Investments directly owns 5,631,319 Ordinary Shares, representing 15.06% of the outstanding Ordinary Shares. Cochlear Limited is the parent company of Cochlear Investments. As a result, Cochlear Limited may be deemed to indirectly beneficially own the Ordinary Shares directly held by Cochlear Investments. The percentage of outstanding Ordinary Shares that may be deemed to be beneficially owned by each Reporting Person is set forth on line 13 of the cover sheet of hereof. Such percentage was calculated based on (i) 34,389,015 Ordinary Shares outstanding as of September 27, 2024, as stated in the Issuer's Form 6-K furnished with the SEC on September 27, 2024, plus (ii) 3.0 million Ordinary Shares sold by the Issuer pursuant to the Issuer’s at-the-market offering, as stated in the Issuer’s Form 6-K furnished with the SEC on October 7, 2024. The Reporting Persons do not have the right to acquire any additional Ordinary Shares. (c) The reported share amounts for the Reporting Persons reflect amounts as of the date hereof. The Reporting Persons have not effected any transactions in the Ordinary Shares during the past 60 days. CUSIP No. B6S7WD106 Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: October 10, 2024 COCHLEAR INVESTMENTS PTY LTD By: /s/ Kristy Jo Name: Kristy Jo Title: Company Secretary COCHLEAR LIMITED By: /s/ Rob McGrory Name: Rob McGrory Title: Company Secretary

View Full Filing

View this SC 13D/A filing on SEC EDGAR